{"id":11186,"date":"2014-05-28T00:00:00","date_gmt":"2014-05-28T00:00:00","guid":{"rendered":"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-announces-second-annual-cancer-immunotherapy-month\/"},"modified":"2022-07-13T04:27:10","modified_gmt":"2022-07-13T04:27:10","slug":"cri-announces-second-annual-cancer-immunotherapy","status":"publish","type":"cri_news","link":"https:\/\/www.cancerresearch.org\/es\/media-room\/cri-announces-second-annual-cancer-immunotherapy","title":{"rendered":"Cancer Research Institute Announces Second Annual Cancer Immunotherapy Month"},"content":{"rendered":"\n

The Cancer Research Institute (CRI) is pleased to host its second annual Cancer Immunotherapy Month<\/a> in June, aimed at increasing awareness of cancer immunotherapy, also known as immuno-oncology, a class of cancer treatment that mobilizes the immune system to fight the disease. Immunotherapy was named Science<\/em> magazine\u2019s 2013 Breakthrough of the Year<\/a>, and is anticipated once again to dominate this year\u2019s annual meeting of the American Society of Clinical Oncology (ASCO) beginning Friday this week.<\/p>\n\n\n\n

As a major initiative of the month, CRI will profile immunotherapy patient success stories\u2014one per day, each day in June\u2014across a broad range of cancers including melanoma, prostate cancer, leukemia, lung cancer, ovarian cancer, and others. This series, called \u201c30 Days, 30 Stories: Surviving Cancer through Immunotherapy,\u201d will be hosted on a new website launching June 1, TheAnswerToCancer.org, which provides patients and their caregivers easy-to-understand information on cancer immunotherapy and connects them to immunotherapy clinical trials.<\/p>\n\n\n\n

Also in June, Grammy winner, film star, and cancer \u201cthriver,\u201d Olivia Newton-John, will appear in a CRI Public Service Announcement (PSA) about cancer immunotherapy. Newton-John, who overcame breast cancer more than 20 years ago, is a vocal advocate for cancer patient health and wellness. She actively supports treatment and research through the Olivia Newton-John Cancer & Wellness Centre at Austin Hospital in Melbourne, Australia, which is leading the way in cancer immunotherapy in Australia.<\/p>\n\n\n\n

\u201cCancer immunotherapy today is producing remarkable and durable remissions in some patients, and this is just the beginning,\u201d said Jill O\u2019Donnell-Tormey, PhD, CEO and director of scientific affairs at the Cancer Research Institute. \u201cSafe and powerful immune-based cancer treatments will become available for patients with other types of cancer over the next five to ten years, so there\u2019s tremendous optimism that we are truly changing the face of cancer.\u201d<\/p>\n\n\n\n

Despite incredible medical advances in the past two years, much of the public are not aware of the ability and potential of immuno-oncology to one day soon offer safer, more effective treatment options for all cancer patients. With significant support from the biotech and pharmaceutical industry as well as leading academic research hospitals, Cancer Immunotherapy Month is helping accelerate the development of immunotherapies by raising funds to support cancer immunotherapy research, increasing awareness and educating the public, and enlisting the help of scientists and clinicians around the world.<\/p>\n\n\n\n

Other important highlights from the month include:<\/p>\n\n\n\n